Antiviral Chemotherapy

Over the past 20 years, antiviral therapy has undergone a revolution and is now making a significant impact on the treatment of major virus diseases, for example HIV and viral hepatitis B and C. Targets include viral reverse transcriptases and proteases. The use of interferon to boost host immunity...

Descripción completa

Detalles Bibliográficos
Autores principales: Burrell, Christopher J., Howard, Colin R., Murphy, Frederick A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149393/
http://dx.doi.org/10.1016/B978-0-12-375156-0.00012-6
_version_ 1783520801379581952
author Burrell, Christopher J.
Howard, Colin R.
Murphy, Frederick A.
author_facet Burrell, Christopher J.
Howard, Colin R.
Murphy, Frederick A.
author_sort Burrell, Christopher J.
collection PubMed
description Over the past 20 years, antiviral therapy has undergone a revolution and is now making a significant impact on the treatment of major virus diseases, for example HIV and viral hepatitis B and C. Targets include viral reverse transcriptases and proteases. The use of interferon to boost host immunity has also proved effective. Our understanding of chemotherapeutic strategies and drug resistance has become considerably more sophisticated since the widespread introduction of routine genome sequencing of virus isolates.
format Online
Article
Text
id pubmed-7149393
institution National Center for Biotechnology Information
language English
publishDate 2017
record_format MEDLINE/PubMed
spelling pubmed-71493932020-04-13 Antiviral Chemotherapy Burrell, Christopher J. Howard, Colin R. Murphy, Frederick A. Fenner and White's Medical Virology Article Over the past 20 years, antiviral therapy has undergone a revolution and is now making a significant impact on the treatment of major virus diseases, for example HIV and viral hepatitis B and C. Targets include viral reverse transcriptases and proteases. The use of interferon to boost host immunity has also proved effective. Our understanding of chemotherapeutic strategies and drug resistance has become considerably more sophisticated since the widespread introduction of routine genome sequencing of virus isolates. 2017 2016-11-11 /pmc/articles/PMC7149393/ http://dx.doi.org/10.1016/B978-0-12-375156-0.00012-6 Text en Copyright © 2017 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Burrell, Christopher J.
Howard, Colin R.
Murphy, Frederick A.
Antiviral Chemotherapy
title Antiviral Chemotherapy
title_full Antiviral Chemotherapy
title_fullStr Antiviral Chemotherapy
title_full_unstemmed Antiviral Chemotherapy
title_short Antiviral Chemotherapy
title_sort antiviral chemotherapy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149393/
http://dx.doi.org/10.1016/B978-0-12-375156-0.00012-6
work_keys_str_mv AT burrellchristopherj antiviralchemotherapy
AT howardcolinr antiviralchemotherapy
AT murphyfredericka antiviralchemotherapy

Ejemplares similares